Company intelligence / Profile preview

Wix

Ownership: Public · WIX
Development stage: Commercial

Overview

WIXBIO is a leading Chinese biotech specializing in the research, development, customization, production, and export of veterinary vaccines. The company holds 288 international/national patents across poultry, livestock, pet & aquatic vaccines. It has established multiple international joint research centers—including the Sino-British International Research Center for Avian Diseases—and is recognized by the Chinese government as a National Postdoctoral Research Station. Its products are at the forefront of safety/efficacy within China’s veterinary biologics industry.

Therapeutic areas: Infectious Diseases
Modalities: VaccineRecombinant proteinProtein
Industry: Veterinary

Financials

Market cap: $3.8B
Total revenue: $563.1M
Enterprise value: $4.9B

Beyond the preview

Go deeper on Wix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wix.

Explore the full profile